Check-Cap (צ'ק קאפ)

Isfiya, Israel

Check-Cap is a clinical-stage medical diagnostics company leading the development of an ingestible imaging capsule that utilizes low-dose X-rays for colorectal cancer (CRC) screening. The Check-Cap device requires no bowel preparation or invasive procedures and is expected to detect clinically significant polyps within the same range of accuracy as a standard colonoscopy. Check-Cap's ultra-low-dose X-ray radar device is being designed to create reconstructed 2D and 3D images of the colon. No prior bowel cleansing is needed because its X-rays create 360 degree angular scans capable of seeing through intestinal content. The exposure to radiation is minimal, and equivalent to a standard chest X-ray. The capsule transmits data to a receiving device attached to the patient's back. The information is stored for a physician's analysis; if the 3D images reveal polyps, a therapeutic colonoscopy can be prescribed as needed. In January 2018, Check-Cap received CE mark approval for its C-Scan system. In September 2018, the company announced that it had received approval from the Israeli Ministry of Health's Medical Device Division (AMAR) to initiate commercial sales of the C-Scan system in Israel.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Check-Cap (צ'ק קאפ) on @MedStartr Today #ColorectalCancer #CancerScreening #Cancer #Diagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/cOllCXPnBMU

Get Involved in Check-Cap (צ'ק קאפ)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2009
Website: www.check-cap.com/

Disease Areas

Colorectal Cancer Cancer Screening

Technologies

Medical DevicesX-RayScreening Technology

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Check-Cap (צ'ק קאפ)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.